News
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.
StockStory.org on MSN1d
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
our findings show how RNA may directly contribute to the stability and evolution of the genome. It's not merely a passive messenger, but an active participant in genome maintenance. These insights ...
Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
3d
Barchart on MSNWhat to Expect From Moderna's Next Quarterly Earnings ReportModerna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...
Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
In the vast and often unseen world of microscopic life, a recent discovery may force scientists to rethink what it means to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results